Amid this uncertainty, equity strategists at HSBC have compiled a list of five catalysts that will determine whether the market will retake its highs and live another day, or relapse deeper into a ...

The increasing costs and complexity of R&D in the pharmaceutical industry have necessitated the adoption of strategic ...